Возраст домена | n/a |
Дата окончания | n/a |
PR | 4 |
ИКС | |
Страниц в Google | 2450 |
Страниц в Яндексе | 41 |
Dmoz | Нет |
Яндекс Каталог | Нет |
Alexa Traffic Rank | 5682716 |
Alexa Country | Нет данных |
История изменения показателей | Авторизация |
Идет сбор информации... Обновить
Home
pharma, news, pharma news, pharmaceutical news, top pharma news, breaking news, breaking pharma news, business news, industry news, EMA news, EC news, research news,
Breaking European Pharmaceutical News
UTF-8
38.48 КБ
624
4 880 симв.
4 121 симв.
Данные предоставлены сервисом semrush
Сайт | Общие фразы | PR | тИЦ | Alexa Rank | Alexa Country | |
---|---|---|---|---|---|---|
![]() ![]() |
12 | 7 |
0 | 3848 | ![]() | |
![]() ![]() |
11 | 7 |
100 | 66520 | ![]() | |
![]() ![]() |
10 | 9 |
0 | 5 | ![]() | |
![]() ![]() |
7 | 8 |
1000 | 4981 | ![]() | |
![]() |
6 | 6 |
0 | 106975 | ![]() | |
![]() ![]() |
5 | 8 |
0 | 113 | ![]() | |
![]() |
5 | 6 |
50 | 21875 | ![]() | |
![]() ![]() |
4 | 7 |
0 | 687 | ![]() | |
![]() ![]() |
4 | 9 |
0 | 2 | ![]() | |
![]() |
4 | 5 |
0 | 1761023 | ![]() | |
Еще 40 сайтов после авторизации |
Данные предоставлены сервисом semrush
Счетчик | Посетители за 24 часа | Просмотры | Просмотров на посетителя |
---|---|---|---|
![]() | Нет доступа | Нет доступа | n/a |
Данные linkpad ( 9 Февраля 2014 ) | |
Количество ссылок на сайт | 69 |
Количество доменов, которые ссылаются на сайт | 31 |
Количество найденных анкоров | 36 |
Исходящие (внешние) ссылки домена | 156 |
Количество доменов, на которые ссылается сайт | 37 |
Количество исходящих анкоров | 30 |
Внешние ссылки главной страницы ( 7 ) | |
worldpharmajobs.com | WORLD PHARMA JOBS |
facebook.com/pages/PharmaNewseu/110595312346047 nofollow | |
twitter.com/PharmaNewsEU nofollow | |
feeds.feedburner.com/pharmanewseu nofollow | - |
worldpharmanews.com | World Pharma News |
ehealthnews.eu | eHealthNews.eu |
healthitspace.eu | (HEALTH IT) SPACE |
Внутренние ссылки главной страницы ( 29 ) | |
pharmanews.eu | PharmaNews.eu |
/business | Business |
/rd | R&D |
/ec | EC |
/ema | EMA |
/events | Events |
/open-calls | Open Calls |
/research | Research |
/research/2165-researchers-find-new-signaling-systems-in-hum... | Read more ... |
/boehringer-ingelheim | Boehringer Ingelheim |
/boehringer-ingelheim/2164-boehringer-ingelheim-advances-fir... | Read more ... |
/astrazeneca | AstraZeneca |
/astrazeneca/2163-astrazeneca-divests-rights-to-seroquel-and... | Read more ... |
/research/2162-one-avocado-a-day-helps-lower-bad-cholesterol... | Read more ... |
/events/2161-smi-s-9th-annual-pharmaceutical-microbiology-uk... | Read more ... |
/research/2160-rare-diseases-over-300-million-patients-affec... | Read more ... |
/ema/2159-first-vaccine-to-protect-against-ebola | Read more ... |
/research/2158-bed-time-is-the-best-time-to-take-blood-press... | Bed time is the best time to take blood pressure medication |
/research/2157-first-entirely-digital-clinical-trial-encoura... | First entirely digital clinical trial encourages physical activity |
/events/2156-fda-should-withdraw-andas-and-new-technologies-... | 'FDA should withdraw ANDAs', and 'new technologies could bring massive improvements in efficiency' if implemented correctly |
/bayer/2155-bayer-launches-lifehub-uk-focused-on-artificial-... | Bayer Launches LifeHub UK Focused on Artificial Intelligence to Optimize Data-Driven Drug Discovery and Disease Diagnosis |
/novartis/2154-novartis-announces-that-jakavi-ruxolitinib-me... | Novartis announces that Jakavi® (ruxolitinib) meets primary endpoint in Phase III study of acute graft-versus-host disease |
/research/2153-ai-could-offer-warnings-about-serious-side-ef... | AI could offer warnings about serious side effects of drug-drug interactions |
/abbott/2152-abbott-and-omada-health-partner-to-offer-integr... | Abbott and Omada Health partner to offer integrated digital health and coaching experience for people with Type 2 diabetes |
/component/banners/click/7 | <img> |
/terms-and-conditions | Terms and Conditions |
/contact | Advertise |
pharmanews.eu/?format=feed&type=rss | RSS 2.0 |
pharmanews.eu/?format=feed&type=atom | Atom 1.0 |
Domain: pharmanews
Registrant:
NOT DISCLOSED!
Visit www.eurid.eu for webbased whois.
Reseller:
Technical:
Name: Host Master
Organisation: united-domains AG
Language: de
Phone: +49.8151368670
Fax: +49.81513686777
Email: hostmaster@united-domains.de
Registrar:
Name: united-domains AG
Website: www.united-domains.de
Name servers:
ns.udagdns.net
ns.udagdns.de
Keys:
Please visit www.eurid.eu for more info.
# If the Joomla site is installed within a folder such as at
# e.g. www.example.com/joomla/ the robots.txt file MUST be
# moved to the site root at e.g. www.example.com/robots.txt
# AND the joomla folder name MUST be prefixed to the disallowed
# path, e.g. the Disallow rule for the /administrator/ folder
# MUST be changed to read Disallow: /joomla/administrator/
#
# For more information about the robots.txt standard, see:
# http://www.robotstxt.org/orig.html
#
# For syntax checking, see:
# http://tool.motoricerca.info/robots-checker.phtml
User-agent: *
Disallow: /administrator/
Disallow: /bin/
Disallow: /cache/
Disallow: /cli/
Disallow: /components/
Disallow: /includes/
Disallow: /installation/
Disallow: /language/
Disallow: /layouts/
Disallow: /libraries/
Disallow: /logs/
Disallow: /modules/
Disallow: /plugins/
Disallow: /tmp/
США - Malvern - 148.177.30.79
Johnson & Johnson
Johnson & Johnson
HTTP/1.1 200 OK
Server: nginx
Date: Mon, 04 Nov 2019 14:08:09 GMT
Content-Type: text/html; charset=utf-8
Transfer-Encoding: chunked
Connection: keep-alive
X-Powered-By: PHP/7.2.15
Expires: Wed, 17 Aug 2005 00:00:00 GMT
Cache-Control: no-store, no-cache, must-revalidate, post-check=0, pre-check=0
Pragma: no-cache
Set-Cookie: d4dad6935f632ac35975e3001dc7bbe8=3vinn5l4timlvjctad327jo4mg; path=/; HttpOnly
Last-Modified: Mon, 04 Nov 2019 14:08:09 GMT
X-Powered-By: PleskLin
Кнопка для анализа сайта в один клик, для установки перетащите ссылку на "Панель закладок"